Sofia Domingos1, Vânia André1,2, Sílvia Quaresma1, Inês C B Martins1, M Fátima Minas da Piedade1,3, Maria Teresa Duarte1. 1. Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal. 2. Centre for research in ceramics and composite materials (CICECO), Department of Chemistry, Universidade de Aveiro, Aveiro, Portugal. 3. Departamento de Química e Bioquímica, Faculdade de Ciências da Universidade de Lisboa (FCUL), Lisbon, Portugal.
Abstract
OBJECTIVES: In a short approach, we want to present the improvements that have recently been done in the world of new solid forms of known active pharmaceutical ingredients (APIs). The different strategies will be addressed, and successful examples will be given. KEY FINDINGS: This overview presents a possible step to overcome the 10-15 years of hard work involved in launching a new drug in the market: the use of new forms of well-known APIs, and improve their efficiency by enhancing their bioavailability and pharmacokinetics. It discusses some of the latest progresses. SUMMARY: We want to present, in a brief overview, what recently has been done to improve the discovery of innovative methods of using well-known APIs, and improve their efficiency. Multicomponent crystal forms have shown to be the most promising achievements to accomplish these aims, by altering API physico-chemical properties, such as solubility, thermal stability, shelf life, dissolution rate and compressibility. API-ionic liquids (ILs) and their advantages will be briefly referred. An outline of what has recently been achieved in metal drug coordination and in drug storage and delivery using bio-inspired metal-organic frameworks (BioMOFs) will also be addressed.
OBJECTIVES: In a short approach, we want to present the improvements that have recently been done in the world of new solid forms of known active pharmaceutical ingredients (APIs). The different strategies will be addressed, and successful examples will be given. KEY FINDINGS: This overview presents a possible step to overcome the 10-15 years of hard work involved in launching a new drug in the market: the use of new forms of well-known APIs, and improve their efficiency by enhancing their bioavailability and pharmacokinetics. It discusses some of the latest progresses. SUMMARY: We want to present, in a brief overview, what recently has been done to improve the discovery of innovative methods of using well-known APIs, and improve their efficiency. Multicomponent crystal forms have shown to be the most promising achievements to accomplish these aims, by altering API physico-chemical properties, such as solubility, thermal stability, shelf life, dissolution rate and compressibility. API-ionic liquids (ILs) and their advantages will be briefly referred. An outline of what has recently been achieved in metal drug coordination and in drug storage and delivery using bio-inspired metal-organic frameworks (BioMOFs) will also be addressed.
Authors: Ilia Alekseevich Repin; Raimar Loebenberg; John DiBella; António C L Conceição; Manuel E Minas da Piedade; Humberto G Ferraz; Michele G Issa; Nadia A Bou-Chacra; Catharine F M Ermida; Gabriel L B de Araujo Journal: AAPS PharmSciTech Date: 2021-01-21 Impact factor: 3.246
Authors: Khaled AbouAitah; Imane M Higazy; Anna Swiderska-Sroda; Reda M Abdelhameed; Stanislaw Gierlotka; Tarik A Mohamed; Urszula Szałaj; Witold Lojkowski Journal: Drug Deliv Date: 2021-12 Impact factor: 6.819
Authors: Tatyana I Shabatina; Yurii N Morosov; Andrey V Soloviev; Andrey V Shabatin; Olga I Vernaya; Michail Y Melnikov Journal: Nanomaterials (Basel) Date: 2021-06-17 Impact factor: 5.076
Authors: João Luís Ferreira da Silva; M Fátima Minas da Piedade; Vânia André; Sofia Domingos; Inês C B Martins; M Teresa Duarte Journal: Molecules Date: 2020-06-11 Impact factor: 4.411